These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 18549920)

  • 1. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
    Oltrona L; Ottani F; Galvani M;
    Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
    Gheno G; Libardoni M; Zeppellini R; Cucchini F
    Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
    Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of C-reactive protein as a short-term prognostic marker in severe unstable angina--a preliminary study.
    Bhagat S; Gaiha M; Sharma VK; Anuradha S
    J Assoc Physicians India; 2003 Apr; 51():349-54. PubMed ID: 12723647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Boersma E; Simoons ML; Zeiher AM;
    Circulation; 2003 Apr; 107(16):2109-14. PubMed ID: 12668510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes.
    Abbate A; Biondi-Zoccai GG; Brugaletta S; Liuzzo G; Biasucci LM
    Semin Vasc Med; 2003 Nov; 3(4):375-84. PubMed ID: 15199444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study.
    Hatmi ZN; Saeid AK; Broumand MA; Khoshkar SN; Danesh ZF
    Acta Med Iran; 2010; 48(1):51-7. PubMed ID: 21137670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A; Sanaa I; Annabi N; Ousji M; Aloui H; Naffeti S
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):899-905. PubMed ID: 16231577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.